Scilex Holding Co - SCLX
Sector:
Healthcare
· Industry:
Biological Products, (No Diagnostic Substances)
Website:
No information yet
· Social:
No information yet
Company profile
Powered by TradingView
Quarter snapshot
Latest / Compare
Q1 2026
· Q4 2025
Value (USD)
Total reported value ($000)
$9.389M
QoQ value delta ($000)
-$4.254M
(-31.18%)
Implied price effect (QoQ)
-33.95%
Shares
Total shares
1,166,855
QoQ shares delta
+47,008
(+4.2%)
Total shares held by funds (by quarter)
Market chart (SCLX)
Powered by TradingView
Interactive chart by
TradingView.
Top holders (Q1 2026)
Top 25 only
Full list
Partial Q1 2026 data: 73 holders have filed so far. Prior holders are carried forward until their next 13F confirms a change.
| Manager | Value ($000) | Shares | % of 13F |
|---|---|---|---|
| VANGUARD GROUP INC | 3,599 | 295,024 | 0.0% |
| ARMISTICE CAPITAL, LLC | 1,982 | 297,706 | 0.04% |
| VANGUARD CAPITAL MANAGEMENT LLC | 1,758 | 264,050 | 0.0% |
| BlackRock, Inc. | 684 | 102,796 | 0.0% |
| VANGUARD FIDUCIARY TRUST CO | 264 | 39,658 | 0.0% |
| RENAISSANCE TECHNOLOGIES LLC | 245 | 36,864 | 0.0% |
| STATE STREET CORP | 235 | 35,376 | 0.0% |
| XTX Topco Ltd | 150 | 22,606 | 0.0% |
| Ashton Thomas Private Wealth, LLC | 119 | 17,989 | 0.0% |
| NORTHERN TRUST CORP | 100 | 15,033 | 0.0% |
| MORGAN STANLEY | 79 | 11,973 | 0.0% |
| CITIGROUP INC | 59 | 8,954 | 0.0% |
| UBS Group AG | 43 | 6,468 | 0.0% |
| Vanguard Global Advisers, LLC | 19 | 2,937 | 0.0% |
| CREATIVE FINANCIAL DESIGNS INC /ADV | 12 | 1,853 | 0.0% |
| ROYAL BANK OF CANADA | 11 | 1,596 | 0.0% |
| MetLife Investment Management, LLC | 7 | 1,090 | 0.0% |
| DEUTSCHE BANK AG\ | 5 | 800 | 0.0% |
| Versant Capital Management, Inc | 5 | 761 | 0.0% |
| JONES FINANCIAL COMPANIES LLLP | 4 | 752 | 0.0% |
| MCF Advisors LLC | 3 | 474 | 0.0% |
| IFP Advisors, Inc | 3 | 576 | 0.0% |
| Activest Wealth Management | 2 | 302 | 0.0% |
| KLP KAPITALFORVALTNING AS | 1 | 290 | 0.0% |
| JPMORGAN CHASE & CO | 0 | 6 | 0.0% |